Castle Biosciences reported revenue of $103.55M and net income of -$2.06M for the quarter ended Jun 2026, up 20.1% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||
| Revenue | 23.48M | 25.04M | 26.85M | 34.84M | 37.01M | 38.34M | 42.04M | 50.14M | 61.49M | 66.12M | 72.97M | 87.00M | 85.78M | 86.31M | 87.99M | 86.19M | 83.04M | 87.01M | 83.68M | 103.55M | |||||||||||||
| Cost of RevenueCost of Rev | 4.50M | 4.60M | 5.94M | 7.69M | 8.86M | 9.52M | 10.18M | 11.06M | 11.32M | 12.42M | 13.89M | 14.52M | 15.61M | 16.18M | 16.38M | 17.63M | 18.70M | 18.32M | 20.53M | 23.70M | |||||||||||||
| Gross Profit | 18.98M | 20.44M | 20.91M | 27.15M | 28.15M | 28.82M | 31.86M | 39.08M | 50.17M | 53.70M | 59.08M | 72.48M | 70.17M | 70.13M | 71.61M | 68.56M | 64.34M | 68.69M | 63.15M | 79.85M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.70M | 1.00M | 1.65M | 2.10M | 2.31M | 2.20M | 2.22M | 2.25M | 2.30M | 2.27M | 2.25M | 2.25M | 2.30M | 2.10M | 28.32M | 2.00M | 2.30M | 2.24M | 2.23M | 2.30M | |||||||||||||
| Research & DevelopmentR&D | 7.50M | 9.45M | 10.76M | 11.93M | 10.91M | 11.31M | 14.39M | 13.31M | 12.92M | 12.99M | 13.81M | 14.14M | 12.32M | 11.77M | 12.59M | 12.79M | 12.96M | 13.52M | 14.43M | 14.54M | |||||||||||||
| Selling, General & AdministrativeSG&A | 22.59M | 25.16M | 30.45M | 37.50M | 36.63M | 38.43M | 46.76M | 44.68M | 44.62M | 44.09M | 48.49M | 51.09M | 50.50M | 49.97M | 58.62M | 58.06M | 55.91M | 56.73M | 64.90M | 66.12M | |||||||||||||
| Other Operating ExpensesOther Opex | 5.19M | 5.61M | 10.15M | -10.62M | 11.01M | 11.44M | 12.40M | 13.31M | 13.59M | 14.69M | 16.14M | 16.77M | 17.88M | 20.52M | 44.71M | 19.59M | 20.98M | 20.59M | 22.76M | 25.95M | |||||||||||||
| Operating ExpensesOpex | 35.29M | 40.21M | 51.37M | 38.81M | 58.55M | 61.17M | 73.56M | 71.30M | 71.13M | 71.78M | 78.44M | 81.99M | 80.70M | 82.26M | 115.92M | 90.44M | 89.85M | 90.84M | 102.09M | 106.62M | |||||||||||||
| Operating IncomeOp. Inc | -11.81M | -15.17M | -24.52M | -3.97M | -21.54M | -22.83M | -31.52M | -21.16M | -9.64M | -5.66M | -5.47M | 5.01M | 5.08M | 4.05M | -27.93M | -4.25M | -6.80M | -3.83M | -18.41M | -3.07M | |||||||||||||
| EBIT | -11.81M | -15.17M | -24.52M | -3.97M | -21.54M | -22.83M | -31.52M | -21.16M | -9.64M | -5.66M | -5.47M | 5.01M | 5.08M | 4.05M | -27.93M | -4.25M | -6.80M | -3.83M | -18.41M | -3.07M | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.27M | 0.20M | 0.09M | 0.02M | 0.02M | 0.02M | 0.02M | 0.13M | 0.19M | ||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | -1.43M | 1.19M | 2.02M | -0.63M | |||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.02M | 0.03M | 0.37M | 1.29M | 2.27M | 0.24M | -0.01M | 2.77M | 3.12M | -0.25M | -0.06M | 3.40M | 3.37M | -0.10M | 2.94M | 2.83M | 2.90M | -0.33M | 2.36M | |||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.05M | 0.10M | -0.44M | -0.15M | |||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -11.79M | -15.15M | -24.49M | -3.60M | -20.25M | -20.56M | -29.19M | -18.76M | -6.87M | -2.54M | -2.49M | 7.89M | 8.28M | 7.88M | -26.27M | -0.14M | -0.39M | -2.71M | -14.41M | -1.69M | |||||||||||||
| Tax ProvisionsTaxes | -1.77M | 0.13M | -1.96M | 0.06M | 0.01M | 0.02M | 0.03M | 0.04M | 0.04M | -1.03M | 6.01M | -1.71M | -0.42M | -4.70M | 0.12M | -0.38M | 0.11M | 0.37M | |||||||||||||||
| Profit After TaxPAT | -11.79M | -6.43M | -24.62M | -1.65M | -20.25M | -20.62M | -29.20M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M | 9.59M | -25.85M | 4.52M | -0.50M | -2.33M | -14.52M | -2.06M | |||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -11.79M | -13.38M | -24.62M | -1.65M | -20.25M | -20.62M | -29.20M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M | 9.59M | -25.85M | 4.56M | -0.50M | -2.33M | -14.52M | -2.06M | |||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -11.79M | -13.38M | -24.62M | -1.65M | -20.25M | -20.62M | -29.20M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M | 9.59M | -25.85M | 4.56M | -0.50M | -2.33M | -14.52M | -2.06M | |||||||||||||
| Income towards Parent CompanyParent Net Inc | -11.79M | -13.38M | -24.62M | -1.65M | -20.25M | -20.62M | -29.20M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M | 9.59M | -25.85M | 4.56M | -0.50M | -2.33M | -14.52M | -2.06M | |||||||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -11.79M | -13.38M | -24.62M | -1.65M | -20.25M | -20.62M | -29.20M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M | 9.59M | -25.85M | 4.56M | -0.50M | -2.33M | -14.52M | -2.06M | |||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.47 | -0.53 | -0.97 | -0.06 | -0.77 | -0.79 | -1.10 | -0.70 | -0.26 | -0.10 | -0.09 | 0.32 | 0.08 | 0.35 | -0.90 | 0.16 | -0.02 | -0.08 | -0.49 | -0.07 | |||||||||||||
| EPS (Diluted) | -0.47 | -0.53 | -0.97 | -0.06 | -0.77 | -0.79 | -1.10 | -0.70 | -0.26 | -0.10 | -0.09 | 0.31 | 0.08 | 0.33 | -0.90 | 0.15 | -0.02 | -0.08 | -0.49 | -0.07 | |||||||||||||
| Shares Outstanding | 25.29M | 25.14M | 25.42M | 26.06M | 26.32M | 26.05M | 26.61M | 26.73M | 26.83M | 26.80M | 27.48M | 27.65M | 27.84M | 27.78M | 28.61M | 28.91M | 29.07M | 28.99M | 29.89M | 30.40M | |||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 25.29M | 25.14M | 25.42M | 26.06M | 26.32M | 26.05M | 26.61M | 26.73M | 26.83M | 26.80M | 27.48M | 28.74M | 29.40M | 29.25M | 28.61M | 29.55M | 29.07M | 28.99M | 29.89M | 30.40M | |||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 25.29M | 25.38M | 25.49M | 26.29M | 26.35M | 26.55M | 26.69M | 26.78M | 26.89M | 27.41M | 27.59M | 27.71M | 27.98M | 28.48M | 28.84M | 28.98M | 29.16M | 29.69M | 30.30M | 30.51M | |||||||||||||
| EBITDA | -11.81M | -15.17M | -24.52M | -3.97M | -21.54M | -22.83M | -31.52M | -21.16M | -9.64M | -5.66M | -5.47M | 5.01M | 5.08M | 4.05M | -27.93M | -4.25M | -6.80M | -3.83M | -18.41M | -3.07M | |||||||||||||
| Interest ExpensesInt Expense | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.27M | 0.20M | 0.09M | 0.02M | 0.02M | 0.02M | 0.02M | 0.13M | 0.19M | ||||||||||||||
| Tax Rate | 11.71% | -0.55% | 54.29% | -0.28% | -0.05% | -0.09% | -0.47% | -1.53% | -1.81% | -13.11% | 72.60% | -21.62% | 1.61% | 3,286.71% | -29.79% | 14.08% | -0.76% | -21.89% |